Mechanisms of catecholamine inactivation by the endocrine pancreas.
D000818:Animals; D065098:Catechol O-Methyltransferase Inhibitors; D002395:Catecholamines / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002478:Cells, Cultured; D003042:Cocaine / Q000378:metabolism; D006224:Cricetinae; D003470:Culture Media; D004298:Dopamine / Q000008:administration & dosage / Q000378:metabolism; D004357:Drug Synergism; D007099:Imipramine / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000201:enzymology / Q000378:metabolism*; D007980:Levodopa / Q000008:administration & dosage; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D009661:Nortriptyline / Q000378:metabolism; D010293:Pargyline / Q000008:administration & dosage; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013268:Stimulation, Chemical; D014191:Tranylcypromine / Q000008:administration & dosage
D065098:Catechol O-Methyltransferase Inhibitors; D002395:Catecholamines; D003470:Culture Media; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D007980:Levodopa; D010293:Pargyline; D009661:Nortriptyline; D008995:Monoamine Oxidase; D003042:Cocaine; D007099:Imipramine; D004298:Dopamine